Attached files
U.
S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
Form 10-Q
(Mark One)
|
þ
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
For
the quarterly period ended NOVEMBER 30, 2009
|
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
Commission
File Number
GENEMEN INC.
(Exact
name of registrant as specified in its charter)
|
Nevada
|
20-2471612
|
|
|
(State
or other jurisdiction of
|
(IRS
Employer Identification No.)
|
|
|
incorporation
or organization)
|
For
correspondence, please contact:
Jillian
Ivey Sidoti, Esq.
34721
Myrtle Court
Winchester,
CA 92596
(323)
799-1342 (phone)
(951)
602-6049 (fax)
3702
South Virginia Street, Suite G12-401
Reno,
Nevada 89502-6030
(Address
of principal executive offices)
(281)
488-3883
(Registrant’s
telephone number, including area code)
Indicate
by check mark whether the
registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing requirements
for the past 90 days. Yes þ No o
Indicate
by check mark whether the
registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of
“large accelerated
filer,” “accelerated
filer,” and “smaller
reporting company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer
|
o |
Accelerated filer
|
o |
Non-accelerated filer
|
o |
Smaller reporting company
|
þ |
|
(Do
not check if a smaller reporting company)
|
Indicate
by check mark whether the
registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act). Yes þ No o
At
January 13, 2010, there were 2,525,000 shares outstanding of
the registrant’s common
stock.
GENEMEN
INC.
INDEX
TO FORM 10-Q
FOR
THE QUARTER ENDED NOVEMBER 30, 2009
|
Page
|
||
|
Number
|
||
| PART I. |
FINANCIAL
INFORMATION
|
|
| Item 1. |
Financial
Statements
|
|
|
Balance
Sheets at November 30, 2009 (unaudited) and May 31, 2009
(audited)
|
F-1
|
|
|
Statements
of Operations for the three and six months ended November 30, 2009 and
2008 (unaudited) and for the period from February 5, 2005 (inception) to
November 30, 2009 (unaudited)
|
F-2
|
|
|
Statement
of Shareholders’ Deficit for the period from February 5, 2005 (inception)
to November 30, 2009 (unaudited)
|
F-3
|
|
|
Statements
of Cash Flows for the six months ended November 30, 2009 and 2008 and for
the period from February 5, 2005 (inception) to November 30, 2009
(unaudited)
|
F-4
|
|
|
Notes
to Condensed Consolidated Interim Financial Statements
(unaudited)
|
F-5
|
|
| Item 2. |
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
8
|
| Item 3. |
Controls
and Procedures
|
9
|
| PART II. |
OTHER
INFORMATION
|
|
| Item 1. |
Legal
Proceedings
|
11
|
| Item 2. |
Unregistered
Sales of Equity Securities and Use of Proceeds
|
11
|
| Item 3. |
Defaults
upon senior securities
|
11
|
| Item 4. |
Submissions
of matters to a vote of securities holders
|
11
|
| Item 5. |
Other
Information
|
11
|
| Item 6. |
Exhibits
|
11
|
| Exhibit 31.1 | ||
| Exhibit 32.1 | ||
| Signature | 12 |
ii
PART I — FINANCIAL
INFORMATION
Item 1. FINANCIAL
STATEMENTS
(A
DEVELOPMENT STAGE COMPANY)
BALANCE
SHEETS
AS
OF NOVEMBER 30 AND MAY 31, 2009
|
November
30,
2009
|
May
31,
2009
|
|||||||
|
(unaudited)
|
(audited)
|
|||||||
|
ASSETS
|
||||||||
|
Current
Assets
|
||||||||
|
Cash
and equivalents
|
$ | 0 | $ | 0 | ||||
|
Prepaid
expenses
|
4,970 | 4,970 | ||||||
|
TOTAL
ASSETS
|
$ | 4,970 | $ | 4,970 | ||||
|
LIABILITIES
AND STOCKHOLDERS’ DEFICIT
|
||||||||
|
Current
Liabilities
|
||||||||
|
Accounts
payable and accrued liabilities
|
$ | 5,000 | $ | 5,000 | ||||
|
Due
to related party
|
67,598 | 63,598 | ||||||
|
Total
current liabilities
|
72,598 | 68,598 | ||||||
|
Stockholders’
Deficit
|
||||||||
|
Common
Stock, $.001 par value, 75,000,000 shares authorized, 2,525,000
shares issued and outstanding
|
2,525 | 2,525 | ||||||
|
Preferred
Stock, $.001 par value, 10,000,000 shares authorized, -0- shares issued
and outstanding
|
0 | 0 | ||||||
|
Additional
paid-in capital
|
61,475 | 61,475 | ||||||
|
Deficit
accumulated during the development stage
|
(131,628 | ) | (127,628 | ) | ||||
|
Total
stockholders’ deficit
|
(67,628 | ) | (63,628 | ) | ||||
|
TOTAL
LIABILITIES AND STOCKHOLDERS’ DEFICIT
|
$ | 4,970 | $ | 4,970 | ||||
See
accompanying notes to financial statements.
F-1
GENEMEN,
INC.
(A
DEVELOPMENT STAGE COMPANY)
STATEMENTS
OF OPERATIONS (UNAUDITED)
FOR
THE THREE AND SIX MONTHS ENDED NOVEMBER 30, 2009 AND 2008
FOR
THE PERIOD FROM FEBRUARY 2, 2005 (INCEPTION) TO NOVEMBER 30, 2009
|
THREE
MONTHS ENDED NOVEMBER 30, 2009
|
THREE
MONTHS ENDED NOVEMBER 30, 2008
|
SIX
MONTHS ENDED NOVEMBER 30, 2009
|
SIX
MONTHS ENDED NOVEMBER 30, 2008
|
PERIOD
FROM FEBRUARY 2, 2005 (INCEPTION) TO NOVEMBER 30, 2009
|
||||||||||||||||
|
REVENUES
|
||||||||||||||||||||
|
EXPENSES
|
||||||||||||||||||||
|
Management
fees (Note 6)
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 13,500 | ||||||||||
|
General
and administrative expenses
|
0 | 0 | 0 | 0 | 0 | |||||||||||||||
|
Professional
fees
|
2,000 | 1,500 | 4,000 | 3,000 | 118,128 | |||||||||||||||
|
NET
LOSS
|
$ | (2,000 | ) | $ | (1,500 | ) | $ | (4,000 | ) | $ | (3,000 | ) | $ | (131,628 | ) | |||||
|
BASIC
AND DILUTED LOSS PER SHARE
|
$ (0.00)
|
$ (0.00)
|
$ (0.00)
|
$ | (0.00 | ) | ||||||||||||||
|
WEIGHTED
AVERAGE COMMON SHARES OUTSANDING: BASIC AND DILUTED
|
2,525,000 | 2,525,000 | 2,525,000 | 2,525,000 | ||||||||||||||||
See
accompanying notes to financial statements.
F-2
GENEMEN,
INC.
(A
DEVELOPMENT STAGE COMPANY)
STATEMENT
OF STOCKHOLDERS’ DEFICIT (UNAUDITED)
PERIOD
FROM FEBRUARY 2, 2005 (INCEPTION) TO NOVEMBER 30, 2009
|
Common
Stock
|
Additional
|
Accumulated
|
||||||||||||||||||
|
Shares
|
Amount
|
Paid
in Capital
|
Deficit
|
Total
|
||||||||||||||||
|
Balance,
February 2, 2005 (Inception)
|
- | $ | 0 | $ | 0 | $ | 0 | $ | 0 | |||||||||||
|
Common
stock issued for cash at $0.02 per share, March 20, 2006
|
2,525,000 | 2,525 | 47,975 | - | 50,500 | |||||||||||||||
|
Donated
services (see Note 5)
|
- | - | 1,500 | - | 1,500 | |||||||||||||||
|
Net
loss for the period ended May 31, 2006
|
- | - | - | (5,500 | ) | (5,500 | ) | |||||||||||||
|
Balance,
May 31, 2006
|
2,525,000 | 2,525 | 49,475 | (5,500 | ) | 46,500 | ||||||||||||||
|
Donated
services (see Note 5)
|
- | - | 6,000 | - | 6,000 | |||||||||||||||
|
Net
loss for the year ended May 31, 2007
|
- | - | - | (64,000 | ) | (64,000 | ) | |||||||||||||
|
Balance,
May 31, 2007
|
2,525,000 | 2,525 | 55,475 | (69,500 | ) | (11,500 | ) | |||||||||||||
|
Donated
services (see Note 5)
|
- | - | 6,000 | - | 6,000 | |||||||||||||||
|
Net
loss for the year ended May 31, 2008
|
- | - | - | (19,068 | ) | (19,068 | ) | |||||||||||||
|
Balance,
May 31, 2008
|
2,525,000 | 2,525 | 61,475 | (88,568 | ) | (24,568 | ) | |||||||||||||
|
Net
loss for the year ended May 31, 2009
|
- | - | - | (39,060 | ) | (39,060 | ) | |||||||||||||
|
Balance,
May 31, 2009
|
2,525,000 | 2,525 | 61,475 | (127,628 | ) | (63,628 | ) | |||||||||||||
| Net loss for the six months ended November 30, 2009 | - | - | - | (39,060 | ) | (39,060 | ) | |||||||||||||
|
Balance,
November 30, 2009
|
2,525,000 | $ | 2,525 | $ | 61,475 | $ | (131,628 | ) | $ | (67,628 | ) | |||||||||
See
accompanying notes to financial statements.
F-3
GENEMEN,
INC.
(A
DEVELOPMENT STAGE COMPANY)
STATEMENTS
OF CASH FLOWS (UNAUDITED)
SIX
MONTHS ENDED NOVEMBER 30, 2009 AND 2008
PERIOD
FROM FEBRUARY 2, 2005 (INCEPTION) TO NOVEMBER 30, 2009
|
SIX
MONTHS ENDED NOVEMBER 30, 2009
|
SIX
MONTHS ENDED NOVEMBER 30, 2008
|
PERIOD
FROM FEBRUARY 2, 2005
(INCEPTION)
TO NOVEMBER 30, 2009
|
||||||||||
|
CASH
FLOWS FROM OPERATING ACTIVITIES
|
||||||||||||
|
Net
loss for the period
|
$ | (4,000 | ) | $ | (3,000 | ) | $ | (131,628 | ) | |||
|
Donated
services
|
0 | 0 | 13,500 | |||||||||
|
Change
in non-cash working capital items
|
||||||||||||
|
Prepaid
expenses
|
0 | 0 | (4,970 | ) | ||||||||
|
Accounts
payable and accrued liabilities
|
0 | 3,000 | 5,000 | |||||||||
|
CASH
FLOWS USED BY OPERATING ACTIVITIES
|
(4,000 | ) | (0 | ) | (118,098 | ) | ||||||
|
CASH
FLOWS FROM FINANCING ACTIVITIES
|
||||||||||||
|
Due
to related party
|
4,000 | 0 | 67,598 | |||||||||
|
Proceeds
from sales of common stock
|
0 | 0 | 50,500 | |||||||||
|
CASH
FLOWS PROVIDED BY FINANCING ACTIVITIES
|
4,000 | 0 | 118,098 | |||||||||
|
NET
INCREASE IN CASH
|
0 | 0 | 0 | |||||||||
|
Cash,
beginning of period
|
0 | 0 | 0 | |||||||||
|
Cash,
end of period
|
$ | 0 | $ | 0 | $ | 0 | ||||||
|
SUPPLEMENTAL
CASH FLOW INFORMATION
|
||||||||||||
|
Interest
paid
|
$ | 0 | $ | 0 | $ | 0 | ||||||
|
Income
taxes paid
|
$ | 0 | $ | 0 | $ | 0 | ||||||
See
accompanying notes to financial statements.
F-4
GENEMEN,
INC.
(A
DEVELOPMENT STAGE COMPANY)
NOTES
TO THE FINANCIAL STATEMENTS
NOVEMBER
30, 2009
NOTE
1 – SUMMARY OF ACCOUNTING POLICIES
Nature of
Business
GENEMEN,
Inc. (“GENEMEN”) is a development stage company and was incorporated in Nevada
on February 2, 2005. The Company is developing an online purchase
anti-fraud software program. GENEMEN operates out of office space owned by a
director and stockholder of the Company. The facilities are provided
at no charge. There can be no assurances that the facilities will
continue to be provided at no charge in the future.
Development Stage
Company
The
accompanying financial statements have been prepared in accordance with
accounting principles for development stage companies. A development
stage company is one in which planned principal operations have not commenced or
if its operations have commenced, there has been no significant revenues there
from.
Basis of
Presentation
The
accompanying financial statements have been prepared in accordance with
accounting principles generally accepted in the United States of America and the
rules of the Securities and Exchange Commission (“SEC”), and should be read in
conjunction with the audited financial statements and notes thereto contained in
the Company’s Form 10-K filed with the SEC as of and for the period ended May
31, 2009. In the opinion of management, all adjustments necessary in
order for the financial statements to be not misleading have been reflected
herein. The results of operations for interim periods are not
necessarily indicative of the results to be expected for the full
year.
Cash and Cash
Equivalents
GENEMEN
considers all highly liquid investments with maturities of three months or less
to be cash equivalents. At November 30, 2009 and May 31, 2009, the
Company had $-0- of cash.
Fair Value of Financial
Instruments
GENEMEN’s
financial instruments consist of cash and cash equivalents, prepaid expenses,
acocunts payable and accrued liabilities, and an amount due to a related party.
The carrying amount of these financial instruments approximates fair value due
either to length of maturity or interest rates that approximate prevailing
market rates unless otherwise disclosed in these financial
statements.
Income
Taxes
Income
taxes are computed using the asset and liability method. Under the
asset and liability method, deferred income tax assets and liabilities are
determined based on the differences between the financial reporting and tax
bases of assets and liabilities and are measured using the currently enacted tax
rates and laws. A valuation allowance is provided for the amount of
deferred tax assets that, based on available evidence, are not expected to be
realized.
F-5
GENEMEN,
INC.
(A
DEVELOPMENT STAGE COMPANY)
NOTES
TO THE FINANCIAL STATEMENTS
NOVEMBER
30, 2009
NOTE
1 – SUMMARY OF ACCOUNTING POLICIES (continued)
Use of
Estimates
The
preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date the financial statements and the
reported amount of revenues and expenses during the reporting
period. Actual results could differ from those
estimates.
Basic loss per
share
Basic
loss per share has been calculated based on the weighted average number of
shares of common stock outstanding during the period.
Recent Accounting
Pronouncements
GENEMEN
does not expect the adoption of recently issued accounting pronouncements to
have a significant impact on the Company’s results of operations, financial
position or cash flow.
Subsequent
Events
We
evaluate the effects of all subsequent events through the date the preparation
of our financial statements is complete, management certifies the financial
statements, and we file the financial statements with the U.S. Securities and
Exchange Commission.
NOTE
2 – DUE TO RELATED PARTY
Amounts
due to a related party totaling $67,598 and $63,598 at November 30, 2009 and May
31, 2009, respectively, are advances made to the Company by a director to be
used to pay operating expenses. The amounts are due upon demand, non-interest
bearing, and unsecured.
Commencing
March 20, 2006, the Company recognized donated services for directors of the
Company for management fees, valued at $500 per month. The donated
services ceased effective June 1, 2008.
NOTE
3 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
Accounts
payable and accrued liabilities at November 30, 2009 and May 31, 2009 were
$5,000. These amounts related to professional fees owed for services
related to periods prior to and including the applicable year-end
date.
NOTE
4 – INCOME TAXES
For the
periods ended November 30, 2009, GENEMEN has incurred net losses and, therefore,
has no tax liability. The net deferred tax asset generated by the
loss carry-forward has been fully reserved. The cumulative net
operating loss carry-forward is approximately $131,500 at November 30, 2009, and
will expire beginning in the year 2027.
F-6
GENEMEN,
INC.
(A
DEVELOPMENT STAGE COMPANY)
NOTES
TO THE FINANCIAL STATEMENTS
NOVEMBER
30, 2009
NOTE
4 – INCOME TAXES (continued)
The
cumulative tax effect at the expected rate of 34% of significant items
comprising our net deferred tax amount is as follows:
|
2009
|
||||
|
Deferred
tax asset attributable to:
|
||||
|
Net
operating loss carryover
|
$ | 44,600 | ||
|
Valuation
allowance
|
(44,600 | ) | ||
|
Net
deferred tax asset
|
$ | - | ||
NOTE
5 – LIQUIDITY AND GOING CONCERN
GENEMEN
has negative working capital, has incurred losses since inception, and has not
yet received revenues from sales of products or services. These
factors create substantial doubt about the Company’s ability to continue as a
going concern. The financial statements do not include any adjustment
that might be necessary if the Company is unable to continue as a going
concern.
The
ability of GENEMEN to continue as a going concern is dependent on the Company
generating cash from the sale of its common stock and/or obtaining debt
financing and attaining future profitable operations. Management’s
plans include selling its equity securities and obtaining debt financing to fund
its capital requirement and ongoing operations; however, there can be no
assurance the Company will be successful in these efforts.
F-7
Item 2. MANAGEMENT’S DISCUSSION
AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
The following discussion and
analysis should be read in conjunction with the consolidated financial
statements and related notes included in this report and those in our 2008
Annual Report on Form 10-K filed with the Securities and Exchange Commission
on August 18,
2009. This discussion
contains forward-looking statements that involve risks and uncertainties. Our
actual results may differ materially from those anticipated in such
forward-looking statements as a result of certain factors, including but not
limited to, those described under “Risk Factors” included in Part II,
Item IA of this report.
Overview
We were
incorporated on February 2, 2005. Under the Securities Act of 1933, our
registration statement was approved by the Securities and Exchange Commission
and declared effective on September 13, 2006.
We are in
the business of developing and marketing an online purchase anti-fraud software
program known as Intellipass, and we will
market our product and provide our software installation, instruction and use
tips through our www.intellipass.com.cn Internet website, to which we have
ownership rights. We are unsure of when our software will be functional due to
our lack of capital and the lack of capital sources. Our efforts will be
directed at markets in China. The Intellipass software program will be designed
to send an instant text message with a one-time use random password to the
purchaser’s cell phone, which is registered with his credit card. This will be
used for verification that the purchaser is really using his own credit card.
Upon completion, we plan to market this software program to Internet storeowners
and e-commerce website designers who are trying to enhance e-commerce security.
Our plan is to earn revenue from licensing our Intellipass software program once
development of this software is complete and our website is fully
operational.
The
following discussion should be read in conjunction with our financial statements
and the related notes that appear elsewhere in this report. The following
discussion contains forward-looking statements that reflect our plans, estimates
and beliefs. Our actual results could differ materially from those discussed in
the forward-looking statements.
Results of Operations for the three
and six months ending November 30, 2009
Assets
Currently,
we have no tangible assets and no intangible assets that are quantifiable. This
is the same as the previous year at November 30, 2008.
Operating
Expense
Total
operating expenses for the three months ended November 30, 2009, were $2,000
compared to expenses for the period ended November 30, 2008 of
$1,500. Total operating expenses for the six months ended November
30, 2009 were $4,000 compared to expenses for the period ended November 30, 2008
of $3,000. This was due to increased costs.
Net Loss
Net loss
for the three months ended November 30, 2009 was negative $(2,000) compared to
the period ended November 30, 2008 of negative $(1,500). Net loss for
the six months ended November 30, 2009 was ($4,000) compared to net loss for the
period ended November 30, 2008 of ($3,000.) This was due to increased
costs.
8
Liquidity and Capital
Resources
At
November 30, 2009, we had $Nil in cash.
Critical Accounting Policies
and Estimates
Our
critical accounting policies are disclosed in our 2008 Annual Report on Form
10-K. During the three months ended November 30, 2009 there have been no
significant changes in our critical accounting policies.
Recent Accounting
Pronouncements
Recent
accounting pronouncements are disclosed in our 2009 Annual Report on Form 10-K,
filed with the Securities and Exchange Commission on August 18, 2009. During the
three months ended November 30, 2009 there have been no new accounting
pronouncements which are expected to significantly impact our consolidated
financial statements.
PLAN
OF OPERATION AND LIQUIDITY
We
currently do not have a plan of operation in furthering the development of our
software. Previously we were developing our Intellipass software, however, due
lack of capital and other resources, we have since been deemed a shell due to
our lack of operations and nominal assets. We are currently revising our
business plan to include plans of obtaining an infusion of capital so we can
resume operations.
Purchase
or Sale of Equipment
We do not
expect to purchase or sell any plant or significant equipment. Our President has
provided server space needed for hosting our website at no charge.
Personnel
Mr.
Qiaozhen Chen, our President and Director and Mr. Jiansheng Hong, our Chief
Technology Officer and Director and Calvin Lum, our director are currently each
working a limited amount of hours per week to meet our needs. As demand
requires, Mr. Chen, Mr. Hong and Mr. Lum will devote additional time. We
currently have no other employees. We expect that we will only increase our
number of employees by one person during the next eighteen months.
Item 3.
CONTROLS AND PROCEDURES
Evaluation of Disclosure
Controls and Procedures
The
Company carried out an evaluation of the effectiveness of the design and
operation of its disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) as of November 30, 2009. This
evaluation was accomplished under the supervision and with the participation of
our chief executive officer / principal executive officer, and chief financial
officer / principal financial officer who concluded that our disclosure controls
and procedures are currently effective to ensure that all material information
required to be filed in the quarterly report on Form 10-Q has been made known to
them.
9
For
purposes of this section, the term disclosure controls and procedures means
controls and other procedures of an issuer that are designed to ensure that
information required to be disclosed by the issuer in the reports that it files
or submits under the Act (15 U.S.C. 78a et seg.) is recorded, processed,
summarized and reported, within the time periods specified in the Commission’s
rules and forms. Disclosure, controls and procedures include, without
limitation, controls and procedures designed to ensure that information required
to be disclosed by in our reports filed under the Securities Exchange Act of
1934, as amended (the "Act") is accumulated and communicated to the issuer's
management, including its principal executive and principal financial officers,
or persons performing similar functions, as appropriate to allow timely
decisions regarding required disclosure.
Based
upon an evaluation conducted for the period ended November 30, 2009, our Chief
Executive Officer and Chief Financial Officer as of November 30, 2009, and as of
the date of this Report, have concluded that as of the end of the periods
covered by this report, they have identified no material weakness of Company
internal controls.
Corporate
expenses incurred are processed and paid by the officers of the
Company. The current number of transactions is not sufficient to
justify the retaining of additional accounting personnel.
Management’s Report on
Internal Control over Financial Reporting
Our
management is responsible for establishing and maintaining adequate internal
control over financial reporting, as such term is defined in
Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Our internal control
system was designed to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external
purposes, in accordance with generally accepted accounting principles in the
United States of America. Our internal control over financial
reporting includes those policies and procedures that (i) pertain to the
maintenance records that, in reasonable detail, accurately and fairly reflect
the transactions and dispositions of the assets of the Company; (ii) provide
reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with accounting principles
generally accepted in the United States of America, and that receipts and
expenditures of the Company are being made only in accordance with
authorizations of management of the Company; and (iii) provide reasonable
assurance regarding prevention or timely detection of unauthorized acquisition,
use, or disposition of the Company’s assets that could have a material effect on
the financial statements.
Because
of inherent limitations, a system of internal control over financial reporting
may not prevent or detect misstatements. Also, projections of any evaluation of
effectiveness to future periods are subject to the risk that controls may become
inadequate due to change in conditions, or that the degree of compliance with
the policies or procedures may deteriorate.
Our
management conducted an evaluation of the effectiveness of our internal control
over financial reporting using the criteria set forth by the Committee of
Sponsoring Organizations of the Treadway Commission (COSO) in Internal
Control—Integrated Framework. Based on its evaluation, our management
concluded that, as of November 30, 2009, our internal control over financial
reporting was effective.
This
quarterly report does not include an attestation report of the Company’s
registered public accounting firm regarding internal control over financial
reporting. Management’s report was not subject to the attestation by the
Company’s registered public accounting firm pursuant to temporary rules of the
SEC that permit the Company to provide only management’s report in this
quarterly report.
10
Changes in Internal Controls
over Financial Reporting
We have
not yet made any changes in our internal controls over financial reporting that
occurred during the period covered by this report that has materially
affected, or is reasonably likely to materially affect, our internal
control over financial reporting.
PART II. OTHER
INFORMATION
Item 1. LEGAL
PROCEEDINGS
In the
ordinary conduct of our business, we are periodically subject to lawsuits,
investigations and claims including, but not limited to, claims involving
students or graduates and routine employment matters. Although we cannot predict
with certainty the ultimate resolution of lawsuits, investigations and claims
asserted against us, we do not believe that any currently pending legal
proceeding to which we are a party will have a material adverse effect on our
business, results of operations, cash flows or financial condition.
None
None
None
None
Item 6.
EXHIBITS
(a) Exhibits:
|
Number
|
Description
|
|||
|
31.1
|
Certification
of Chief Executive and Financial Officer pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002. (Filed herewith.)
|
|||
|
32.1
|
Certification
of Chief Executive and Financial Officer pursuant to 18 U.S.C. §1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
(Filed herewith.)
|
|||
11
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
| GENEMEN INC. | |||
|
Date:
January 13,
2010
|
By:
|
/s/Qiaozhen Chen | |
| Name: Qiaozhen Chen | |||
| Title:
President, Chief Financial Officer and Director
(Principal
Executive Officer, Principal Financial Officer and Principal Accounting
Officer)
|
|||
|
Date:
January 13,
2010
|
By: |
/s/ Qiaozhen Chen
|
|
|
Director
|
|||
|
Name:
Qiaozhen Chen
|
|||
|
Title:
Director
|
12